Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.57826 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.39692 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.41398 | 56 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.25245 | 53 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.31068 | 55 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.65144 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.63369 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.40102 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.34095 | 55 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.42283 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.40911 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.3268 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.13043 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.54444 | 59 |